Princess Margaret Cancer Program will implement ComprehensiveBMT and Investigate Cell Therapy to continue leading role in cancer care and research

SALT LAKE CITY , Nov. 14, 2012 /CNW/ - Remedy Informatics, the leading provider of registries and research informatics software for Life Science and Translational Research and Healthcare, today announced the Princess Margaret Cancer Centre at University Health Network in Toronto has selected ComprehensiveBMT and Investigate Cell Therapy, two of Remedy's innovative clinical informatics solutions.

(Logo: http://photos.prnewswire.com/prnh/20120206/SF47874LOGO)

"The Princess Margaret is one of the largest comprehensive cancer facilities in the world with the largest Blood and Marrow Transplant program in Canada and a gold standard cancer research facility," said Gary Kennedy , Founder and CEO of Remedy Informatics. "Both InvestigateCT and ComprehensiveBMT offer unmatched integration of information to improve treatment outcomes by aggregating, mapping, harmonizing and analyzing data across clinical and scientific disciplines. Valuable information will give valuable insights into patient safety, patient survivorship, and quality improvement for transplant physicians, nurses and researchers."

Built on Remedy's flagship Mosaic Platform, InvestigateCT and ComprehensiveBMT offer the Princess Margaret the world's first and only truly integrated research management system. In addition to combining blood and marrow registries with cell therapy laboratories and biobanks, clinicians and researchers will have an unprecedented view of their data through the Mosaic Ontology, which aggregates, maps and harmonizes the data to facilitate pattern recognition. Together researchers are able to manage and aggregate more data sources, across disciplines, including next-generation sequencing, cross-disease registries, LIMS and the Blood and Marrow Transplant Program to advance research of cell therapies, blood and marrow transplantation, and related diseases.

"The future of patient care and innovative research in blood and marrow transplantation requires rapid data analysis to track and improve patient outcomes. We are confident Remedy Informatics can meet our needs," said Dr. John Kuruvilla , MD, FRCP(C), director, Clinical Program, Blood and Marrow Transplant program at the Princess Margaret . "We foresee better information management as the cornerstone for improving patient outcomes in hematologic malignancies."

The Princess Margaret BMT program has an international reputation as a global leader in clinical and research programs and as a gold standard in transplant technologies like Apheresis collections for peripheral stem cell transplant infusions and Extracorporeal Photopheresis for selected graft-vs-host conditions. Over the next year, Remedy will work with the Princess Margaret BMT program to implement InvestigateCT, the world's first Integrated Research Management System designed for cancer centers involved in clinical research using cell therapies. InvestigateCT will facilitate multi-directional data flow throughout the BMT program, cell therapy labs and biobanks to improve real-time analytics, therapies, patient safety, and quality across the transplant care pathway as well as long-term patient survivorship for patients who are living longer and healthier lives.

Remedy serves a wide range of leading Life Science and Translational Research institutions across the country, including the Huntsman Cancer Institute at the University of Utah, Cleveland Clinic's Bariatric and Metabolic Institute and Heart and Vascular Institute, the American Joint Replacement Registry, Baylor Health Care System, and many more.

For more information about Investigate Cell Therapy or ComprehensiveBMT, or Remedy's leading patient registry technology, please visit our website, http://www.remedyinformatics.com. InvestigateCT is for research use only and is not intended for clinical or cell processing purposes.

About Remedy Informatics, Inc.

Original post:
The Princess Margaret BMT Program Chooses Remedy Informatics' Blood and Marrow Transplant & Cell Therapy Solutions to ...